Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Analyst: Biopharma, Now Stronger Than Ever, Is an Ideal Takeout Target

An argument is made in a ROTH Capital Partners report for a potential imminent deal involving this drug maker. In an April 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed the reasons why Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ) is "high on the...
Streetwise Reports | April 18, 2019 |

The Next Takeout Targets in Gold

There have been close to $6 billion in gold buyouts the last 2 weeks. Coming into tax loss season, it’s time to sharpen your pencils and get your cash ready for opportunities on the horizon. The deals that happened over the last 2 weeks should not co...
Marin Katusa | November 29, 2019 |

Analyst: Copper Explorer Is Prime Takeout Target

A Fundamental Research Corp. report explained the reasons why. In a March 15 research note, Fundamental Research Corp. analyst Siddharth Rajeev wrote that Quaterra Resources Inc.'s (QTA:TSX.V; QTRRF:OTCQX) "low valuation metrics make it an acquisition target." Rajee...
Streetwise Reports | March 25, 2019 |

This stealth rally is about to explode into a huge bull market

It was a "stealth" rally... Over the first couple months of 2010, the U.S. stock market hovered around breakeven. Investors were too busy worrying about Greece's debt crisis, fourth-quarter earnings, and health care reform to notice what was happening over in my c...
Dr. George Huang | October 28, 2012 |

With Its Val d'Or Assets, Exploration Company 'On Track to Get Serious Attention'

The recently released resource estimate and other reasons why this Canadian firm makes a premium takeout target are provided in an iA Securities report. In a Sept. 3 research note, iA Securities analyst George Topping reported that the size, potential and location of ...
Streetwise Reports | September 9, 2019 |

Explorer With 'Highly Undervalued Stock' Increases Project Resource

The report updates and the company being a takeout target are discussed in an iA Securities report. In a Jan. 7 research note, iA Securities analyst George Topping reported that Rubicon Minerals Corp. (RMX:TSX; RBYCF:OTCMKTS) updated the mineral resource at its Phoe...
Streetwise Reports | January 15, 2020 |

Turning Over a New Leaf. Environmentally and Profitably

(Click image to play video) They’re the company that’s delivering “better everyday products from plants, not petroleum.” And they’re good natured ® Products Inc. ( TSX-V: G...
Dave Jackson | June 7, 2021 |

Coverage Initiated on Producer of Hemp-Derived Cannabidiol Products

A ROTH Capital Partners report presented the reasons for investing in this company. In a March 7 research note, analyst Scott Fortune reported that ROTH Capital Partners initiated coverage on Charlotte's Web Holdings Inc. (CWEB:CSE; CWBHF:OTCQX) with a Buy rating and ...
Streetwise Reports | March 11, 2019 |

Target Price Raised on Metals Firm 'Growing Substantial High-Grade Project'

The newly announced resource update and what it means in terms of project economics is captured in a ROTH Capital Partners report. In a March 18 research note, analyst Jake Sekelsky reported that ROTH Capital Partners raised its target price on Buy-rated SilverCrest Me...
Streetwise Reports | March 22, 2019 |

Antibody Developer Taken Out by Gilead at 'Hefty Premium'

The reasons Forty Seven attracted a buyer and its near-term catalysts are provided in a BTIG report. In a March 2 research note, BTIG analyst Robert Hazlett reported that Forty Seven Inc. (FTSV:NASDAQ) is being acquired by Gilead Sciences Inc. (GILD:NASDA...
Streetwise Reports | March 5, 2020 |
1 2 3